Indication & Dosage:
Lorbrexen (Lorlatinib), generic Lorbrena is a prescription medicine used to treat metastatic non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. It is used in patients who have already received alectinib, ceritinib or both crizotinib and at least 1 other medicine to treat NSCLC that is caused by the ALK gene. Lorbrexen is manufactured by Everest Pharma Ltd. in Bangladesh.
Have to take it orally once a day with or without food.
The most common adverse reactions are:
Tiredness, constipation, nausea/ vomiting, diarrhea, numbness/ tingling of arms/ legs, swelling ankles/ feet/ hands, dizziness, headache, trouble sleeping, weight gain, muscle/ joint pain, or vision changes.
The above information comes from the Internet. Please consult with doctor for medical advice.
* Any advice on the use of the drug is for reference only. Please consult with doctor for medical advice. All Names, logos, trademarks are property of their respective owners. Watermarks, QR codes are used for identification purposes only.